J Appl Biomed 14:49-57, 2016 | DOI: 10.1016/j.jab.2015.06.003

Cetrorelix and Triptorelin active immunization influences follicle development and receptor expressions of ovaries in mice

Wei Suochenga,b, Gong Zhuandic, An Lifengc, Zhang Taojieb, Zhang Fengweib, Chen Shiena,*
a Engineering & Technology Research Center of Animal Cells of Gansu Province, Northwest University for Nationalities, Lanzhou, China
b Life Science and Engineering College, Northwest University for Nationalities, Lanzhou, China
c Medicine College, Northwest University for Nationalities, Lanzhou, China

The study investigated comparatively the effects of active immunization of Cetrorelix and Triptorelin on the follicle development, histological structures, and expressions of FSHR and LHR proteins in the ovary. One hundred and five female mice, 35 days old, and body weight of 26.56 ± 2.89 g, were randomly assigned into Cetrorelix (CET), Triptorelin (TRI) and control groups (CG). Mice in CET-1, CET-2 and CET-3 (n = 15) were subcutaneously injected with 0.1, 0.2 and 0.4 mL Cetrorelix antigen (100 μg/mL) for seven days, respectively. Mice in TRI-1, TRI-2 and TRI-3 were injected with 0.1, 0.2 and 0.4 mL Triptorelin antigen (100 μg/mL) for seven days. Mice in CG (n = 15) were injected with 0.2 mL saline for seven days. Western blotting was utilized to determine the expressions of follicle stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHR) proteins. ELISA was used to measure the serum FSH and LH concentrations. The ovarian slices were observed under optical microscopy. The results showed that the ovarian weights of CET and TRI groups increased slightly with a maximum increment of 27.02% of CET-1 mice on day 35. Ovarian weights in TRI group increased dose-dependently with a maximum increment of 45.77% in TRI-3 on day 35. The numbers of the primordial follicle (POF), primary follicle (PF), secondary follicle (SF) and mature follicle (MF) of CET and TRI groups increased at different degrees when compared to CG. The granular layer in SF was arranged tightly and zona pellucida (ZP) was thickened. Follicles developed fully. Follicle longitudinal diameter (FLD), follicle transverse diameter (FTD) and follicle wall thickness (FWT) in CET and TRI groups increased as compared to CG. FLD, FTD and FWT of TRI-3 had a larger increment than CG and CET-1 on days 21 and 35. Expression levels of FSHR and LHR proteins in TRI group increased when compared to CG. Expression levels of FSHR and LHR proteins of CET group decreased. Serum FSH of TRI group was slightly higher than the CG and CET group on day 21. On day 35, serum FSH levels of CET-1 and TRI-1 were greater than CG and the rest of the subgroups. Serum FSH levels had no significant differences among all groups. Expression levels of LHR and FSHR proteins in CET group had obvious negative correlations to FLD, FTD and FWT. However, in the TRI group, these correlations were positive. In conclusion, Cetrorelix and Triptorelin immunization could improve ovarian growth, increase the follicle numbers, enhance dose-dependently the FLD, FTD and FWT, and eventually promote the ovary and follicle development. Cetrorelix decreased expression levels of FSHR and LHR proteins in the ovaries of mice. Triptorelin enhanced expression levels of FSHR and LHR proteins. Triptorelin treatment had more obvious effects than Cetrorelix treatment.

Keywords: Cetrorelix; Triptorelin; Active immunization; Follicle; Receptor; Microstructure; Mice

Received: February 21, 2015; Revised: June 19, 2015; Accepted: June 23, 2015; Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Wei S, Gong Z, An L, Zhang T, Zhang F, Chen S. Cetrorelix and Triptorelin active immunization influences follicle development and receptor expressions of ovaries in mice. J Appl Biomed. 2016;14(1):49-57. doi: 10.1016/j.jab.2015.06.003.
Download citation

References

  1. Albano, C., Felberbaum, R.E., Smitz, J., Riethmullerwinzen, H., Engel, J., Diedrich, K., Devroey, P., 2000. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormonereleasing hormone (LHRH)-antagonist Cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum. Reprod. 15, 526-531. Go to original source... Go to PubMed...
  2. Al-Inany, H., Aboulghar, M., 2002. GnRH antagonist in assisted reproduction: a Cochrane review. Hum. Reprod. 17, 874-885. Go to original source... Go to PubMed...
  3. Anjum, S., Krishna, A., Sridaran, R., Tsutsui, K., 2012. Localization of gonadotropin-releasing hormone (GnRH), gonadotropin-inhibitory hormone (GnIH), kisspeptin and GnRH receptor and their possible roles in testicular activities from birth to senescence in mice. J. Exp. Zool. A: Ecol. Genet. Physiol. 317, 630-644. Go to original source... Go to PubMed...
  4. Bartolome, J.A., Sozzi, A., McHale, J., Melendez, P., Arteche, A.C. M., Silvestre, F.T., 2005. Resynchronisation of ovulation and timed insemination in lactating dairy cows: II. Assigning protocols according to stages of the estrous cycle, or presence of ovarian cysts or anestrus. Theriogenology 63, 1628-1642. Go to original source... Go to PubMed...
  5. Bertschinger, H.T., Jago, I., Nothing, J.O., 2006. Repeated use of the GnRH analogue deslorelin to down-regulate reproduction in male cheetahs (Acinonyx jubatus). Theriogenology 66, 1762-1768. Go to original source... Go to PubMed...
  6. Bo, Y., Jane, R., Gregory, C., 2011. The role of peripheral gonadotropin-releasing hormone receptors in female reproduction. Fertil. Steril. 95, 465-473. Go to original source... Go to PubMed...
  7. Chryssa, M., Frank, K., Klaus, D., Nikos, N., Byron, A., 2012. The effects of cetrorelix and triptorelin on the viability and steroidogenesis of cultured human granulosa luteinized cells. In Vivo 26, 835-839. Go to PubMed...
  8. Clarke, I.J., Brown, B.W., Tran, V.V., Scott, C.J., Fry, R., Millar, R.P., 1998. Neonatal immunization against gonadotropinreleasing hormone (GnRH) results in diminished GnRH secretion in adulthood. Endocrinology 139, 2007-2014. Go to original source... Go to PubMed...
  9. Coccia, M.E., Comparetto, C., Bracco, G.L., Scarselli, G., 2004. GnRH antagonists. Eur. J. Obstet. Gynecol. Reprod. Biol. 115, S44-S56. Go to original source... Go to PubMed...
  10. Crawford, J.L., Heath, D.A., Haydon, L.J., Thomson, B.P., Eckery, D.C., 2009. Gene expression and secretion of LH and FSH in relation to gene expression of GnRH receptors in the brushtail possum (Trichosurus vulpecula) demonstrates highly conserved mechanisms. Reproduction 137, 129-140. Go to original source... Go to PubMed...
  11. Danforth, D.R., Arbogasta, L.K., Friedman, C.I., 2005. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil. Steril. 83, 1333-1338. Go to original source... Go to PubMed...
  12. Eman, A., Fouad, K.M.H., Mohammed, A., 2013. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice. Arch. Gynecol. Obstet. 287, 1023-1029. Go to original source... Go to PubMed...
  13. Gong, Z., Wei, S., Wei, M., 2011. GnRHa enhances LH and FSH secretion, ovarian development in female rabbits. Basic Clin. Med. 31, 13-18.
  14. Halmos, G., Schally, A.V., 2002. Changes in subcellular distribution of pituitary receptors for luteinizing hormonereleasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix. Proc. Natl. Acad. Sci. U. S. A. 99, 961-965. Go to original source... Go to PubMed...
  15. Horvath, J.E., Bajo, A.M., Schally, A.V., Kovacs, M., Herbert, F., Groot, K., 2002. Effects of long term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist decapeptyl and the LHRH antagonist cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats. Proc. Natl. Acad. Sci. U. S. A. 99, 15048-15053. Go to original source... Go to PubMed...
  16. Hosseini, M.A., Aleyasin, A., Saeedi, H., Mahdavi, A., 2010. Comparison of gonadotropin releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients. J. Obstet. Gynaecol. Res. 36, 605-610. Go to original source... Go to PubMed...
  17. Huirne, J.A.F., Lambalk, C.B., 2001. Gonadotrophin-releasing hormone receptor antagonists. Lancet 358, 1793-1803. Go to original source... Go to PubMed...
  18. Huriye, A., Parlakgumus, E.B., Kilicdag, F.A., Bolat, B.H., Alper, P., 2014. GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe? Arch. Gynecol. Obstet., http://dx.doi.org/10.1007/s00404-0143564-2. Go to original source...
  19. Janssens, R.M., Brus, L., Cahill, D.J., Huirne, J.A., Schoemaker, J., Lambalk, C.B., 2000. Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Hum. Reprod. Update 6, 505-518. Go to original source... Go to PubMed...
  20. Jeruss, J.S., Woodruff, T.K., 2009. Preservation of fertility in patients with cancer. N. Engl. J. Med. 360, 902-911. Go to original source... Go to PubMed...
  21. Jiang, C., Zheng, R., Zhang, Y., 2010. Study on mini-dose depot gonadotropin releasing hormone agonist for short protocol. Chin. J. Fam. Plan. 7, 423-426.
  22. Kåss, A.S., Førre, Ø.T., Fagerland, M.W., Gulseth, H.C., Torjesen, P.A., Hollan, I., 2014. Short term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study. Scand. J. Rheumatol. 43, 22-27. Go to original source... Go to PubMed...
  23. Kerimoglu, O.S., 2014. Low dose GnRH antagonist does not help prevent a premature LH surge. Fertil. Wkly. 28, 10.
  24. Khan, T.H., Beck, N.F.G., Khalid, M., 2007. The effects of GnRH analogue (buserelin) or hEG-IV (Chorulon) at day 12 of pregnancy on ovarian function, plasma hormone concentrations, conceptus growth and placentation in ewes and ewe lambs. Anim. Reprod. Sci. 102, 247-257. Go to original source... Go to PubMed...
  25. Li, J., Xu, H., 2008. The effect of down-regulation with GnRHa on the threshold of gonadotrophin for folliculogenesis. J. Reprod. Med. 17, 404-406.
  26. Li, X., Kang, X., Deng, Qi., Cai, J., Wang, Z., 2013. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study. Reprod. Biol. Endocrinol. 11, 1-8. Go to original source... Go to PubMed...
  27. Liu, Y., Tian, Y., Zhao, X., Jiang, S., Li, F., Zhang, Y., Zhang, X., 2015. Immunization of dogs with recombinant GnRH-1 suppresses the development of reproductive function. Theriogenology 83, 314-319. Go to original source... Go to PubMed...
  28. Lopot, M., Ciechanowska, M., Malewski, T., 2008. Changes in the GnRH mRNA and GnRH receptor (GnRH-R) mRNA levels in the hypothalamic-anterior pituitary unit of anestrous ewes after infusion of GnRH into the third cerebral ventricle. Reprod. Biol. 8, 149-161. Go to original source... Go to PubMed...
  29. Magdolna, K., Andrew, V.S., 2001. Comparison of mechanisms of action of luteinizing hormone releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats. Proc. Natl. Acad. Sci. U. S. A. 98, 12197-12202. Go to original source... Go to PubMed...
  30. Marci, R., Graziano, A., Lo Monte, G., Piva, I., Soave, I., Marra, E., Lisi, F., Moscarini, M., Caserta, D., 2013. GnRH antagonists in assisted reproductive techniques: a review on the Italian experience. Eur. Rev. Med. Pharmacol. Sci. 17, 853-857. Go to PubMed...
  31. Meirow, D., Assad, G., Dor, J., Rabinovici, J., 2004. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum. Reprod. 19, 1294-1299. Go to original source... Go to PubMed...
  32. Mo, Y., Peng, P., Zhou, R., He, Z., Huang, L., Yang, D., 2010. Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist. Reprod. Sci. 17, 68-77. Go to original source... Go to PubMed...
  33. Montorsi, F., Tomlinson, P., 2015. Which luteinising hormonereleasing hormone agonist injection schedule do men with prostate cancer prefer? Results of a European patient survey. Eur. Urol. 67, 177-179. Go to original source... Go to PubMed...
  34. Ni, Y.D., Zhou, Y.C., Lu, L.Z., 2007. Developmental changes of FSHR, LHR, ER-b and GnRH-I expression in the ovary of prepubertal ducks (Anas platyrhynchos). Anim. Reprod. Sci. 100, 318-328. Go to original source... Go to PubMed...
  35. Parlakgumus, H.A., Kilicdag, E.B., Bolat, F.A., Haydardedeoglu, B., Parlakgumus, A., 2014. GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe? Arch. Gynecol. Obstet. 99-128. Go to original source...
  36. Roulier, R., Chabert-Orsini, V., Sitri, M.C., Barry, B., Terriou, P., 2003. GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment. Reprod. Biomed. Online 7, 185-189. Go to original source... Go to PubMed...
  37. Rupesh, K.G., Jodi, A.F., 2005. Gonadotropin-releasing hormone (GnRH) analogues and the ovary: do GnRH antagonists destroy primordial follicles. Fertil. Steril. 83, 1339-1342. Go to original source... Go to PubMed...
  38. Seitz, S., Buchholz, S., Schally, A.V., Weber, F., KlinkhammerSchalke, M., Inwald, E.C., Perez, R., Rick, F.G., Szalontay, L., Hohla, F., Segerer, S., 2014. Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS and AEZS. BMC Cancer 14, 847. Go to original source... Go to PubMed...
  39. Soltysik, K., Czekaj, P., Suszka-Switek, A., Kociszewska, K., Plewka, D., 2014. Changes in the subcellular and tissue location of estrogen and progesterone receptors in rat uterus after long term treatment with analogs of gonadoliberin. Ginekol. Pol. 85, 254-263. Go to original source... Go to PubMed...
  40. Sullivan, S.K., Hoare, S.R., Fleck, B.A., Zhu, Y.F., Heise, C.E., Struthers, R.S., Crowe, P.D., 2006. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism. Biochem. Pharmacol. 72, 838-849. Go to original source... Go to PubMed...
  41. Tarlatzis, B.C., Kolibianakis, E.M., 2007. GnRH agonists vs antagonists. Best Pract. Res. Clin. Obstet. Gynaecol. 1, 57-65. Go to original source... Go to PubMed...
  42. Trimino, E., Pinilla, L., Aguilar, E., 1993. Pituitary-gonadal function in neonatal and adult female rats treated with gonadotropin releasing hormone agonist and antagonist: short- and longterm effects. Acta Endocrinol. (Copenh.) 129, 251-259. Go to original source... Go to PubMed...
  43. Wei, S., Gong, Z., Wei, M., Zhao, X., 2010. Effects of GnRH analogue active immunization on reproductive hormones. Chin. J. Lab. Anim. 18, 75-81.
  44. Wei, S., Bai, J., Gong, Z., Ma, W., Wei, M., 2011. GnRH agonist active immunization influences ovarian development and GnRH receptor mRNA expression levels of pituitary in Japanese white rabbits (Oryctolagus cuniculus). Livest. Sci. 139, 222-229. Go to original source...
  45. Wei, S., Gong, Z., Ma, W., Wei, M., 2012. Effects of GnRH agonist on reproductive functions of female rabbits. Anim. Sci. Pap. Rep. 30, 73-86.
  46. Wei, S., Chen, S., Gong, Z., Ouyang, X., An, L., Xie, K., Dong, J., Wei, M., 2013a. Alarelin active immunization influences expression levels of GnRHR, FSHR and LHR proteins in the ovary and enhances follicular development in ewes. Anim. Sci. J. 84, 466-475. Go to original source... Go to PubMed...
  47. Wei, S., Ouyang, X., Ayimu, G., Li, Q., Gong, Z., Xie, K., 2013b. GnRHa active immunity regulates expression of LHR protein and development of uteri in ewes. J. Appl. Anim. Res. 41, 375-381. Go to original source...
  48. Wei, S., Zhang, J., 2008. Preparation of GnRHa antigen and researches on efficacies of active immunization castration with different dosage. J. Northwest Univ. Natl. 19, 49-52.
  49. Zamaratskaia, G., Rydhmer, L., Andersson, H.K., 2007. Long-term effect of vaccination against gonadotropin releasing hormone, using ImprovacTM, on hormonal profile and behaviour of male pigs. Anim. Reprod. Sci. 81, 662-665.
  50. Zhang, J., 2007. Reproduction Endocrinology of Livestocks. Higheducation Press, Beijing, 286-216.